Your browser doesn't support javascript.
loading
Phosphodiesterase 4 inhibitors have wide-ranging activity in B-cell malignancies.
Cooney, Jeffrey D; Aguiar, Ricardo C T.
Affiliation
  • Cooney JD; Division of Hematology and Medical Oncology, Department of Medicine.
  • Aguiar RC; MD/PhD Program.
Blood ; 128(25): 2886-2890, 2016 12 22.
Article in En | MEDLINE | ID: mdl-27756749
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / Phosphodiesterase 4 Inhibitors / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Blood Year: 2016 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / Phosphodiesterase 4 Inhibitors / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Blood Year: 2016 Document type: Article Country of publication: Estados Unidos